We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
This web publication constitutes a notice for the purposes of regulation 42ZCZP of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulation 42ZCZP, this notice sets out:
- the interim decisions made by a delegate of the Secretary under regulation 42ZCZN in relation to proposed amendments to the current Poisons Standard which were referred to an expert advisory committee under subdivision 3D.2 of the Regulations in June 2022;
- the proposed date of effect of the proposed amendments (in circumstances where the interim decision proposes an amendment to the current Poisons Standard).
In accordance with regulation 42ZCZP, interested persons (including the applicant requesting the amendment) are invited to make submissions to the Secretary in relation to these interim decisions on or before 24 November 2022.
Please note that there are two consultations hubs relating to this notice:
- Submissions relating to the decisions regarding PSILOCYBINE and MDMA should be provided through the consultation hub for PSILOCYBINE AND MDMA
- Submissions relating to any other item in the notice should be provided through the alternate consultation hub.
Submissions will be considered by the Delegate in making the final decision.
Please note that in accordance with subregulation 42ZCZQ(4) of the Regulations, the Secretary must publish all relevant submissions received, unless the Secretary considers the information to be confidential information.
If you have difficulty accessing the consultation hub or uploading your submission, contact medicines.scheduling@health.gov.au and include 'Proposed Amendments to the Poisons Standard (Medicines)' or 'Proposed Amendments to the Poisons Standard (Chemicals)' in the subject line of the email.
Interim decision
- Notice of interim decisions on proposed amendments to the Poisons Standard –ACMS#38, Joint ACMS-ACCS#31, ACCS #34 meetings, June 2022 (pdf, 528kb)
- Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS#38, Joint ACMS-ACCS#31, ACCS #34 meetings June 2022 (docx, 286kb)
We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au.
Contents
- 1 Notice of interim decisions made under Regulation 42ZCZN of the Therapeutic Goods Regulations 1990
- 2 Interim decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS meeting #38, June 2022)
- 2.1 Interim decision in relation to cetirizine
- 2.2 Interim decision in relation to budesonide
- 2.3 Interim decisions in relation to psilocybine and MDMA
- 2.4 Interim decision in relation to apronal (allylisopropylacetylurea)
- 3 Interim decisions on proposed amendments referred to the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS meeting #31, June 2022)
- 3.1 Interim decision in relation to helional
- 3.2 Interim decision in relation to hydroxypinacolone retinoate
- 3.3 Interim decision in relation to MDMA and MDA (nomenclature)
- 4 Interim decisions on proposed amendments referred to the Advisory Committee on Chemicals Scheduling (ACCS meeting #34, June 2022)
- 4.1 Interim decision in relation to dichloromethane (methylene chloride)
- 4.2 Interim decision in relation to ipflufenoquin